Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 2—February 2024
Dispatch

Adapting COVID-19 Contact Tracing Protocols to Accommodate Resource Constraints, Philadelphia, Pennsylvania, USA, 2021

Seonghye Jeon1Comments to Author , Lydia Watson-Lewis1, Gabriel Rainisch, Chu-Chuan Chiu, François M. Castonguay, Leah S. Fischer, Patrick K. Moonan, John E. Oeltmann, Bishwa B. Adhikari, Hannah Lawman23, and Martin I. Meltzer2
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Jeon, G. Rainisch, F.M. Castonguay, L.S. Fischer, P.K. Moonan, J.E. Oeltmann, B.B. Adhikari, M.I. Meltzer); Philadelphia Department of Public Health, Philadelphia, Pennsylvania, USA (L. Watson-Lewis, C.-C. Chiu, H. Lawman); University of Montreal School of Public Health, Montreal, Quebec, Canada (F.M. Castonguay)

Main Article

Table 2

Calculated CICT effectiveness values and model-estimated CICT effectiveness before and after CICT protocol change, Philadelphia, Pennsylvania, USA, 2021*

Characteristic Period 1, before protocol change Period 2, after protocol change
Calculated CICT effectiveness values
% Case-patients and contacts isolated because of CICT (range)† 17 (11.7–21.9) 10 (6.7–12.5)
Days from infection to isolation‡
9
8
Model-estimated CICT effectiveness
No. cases averted by CICT 657–968 1,156–1,609
No. hospitalizations averted by CICT 16–24 28–40
% Disease prevalence averted by CICT 8.4–12.0 6.8–9.2
Average staff hours per case averted§ 21–30 8–11
Average staff hours per 1% disease prevalence averted¶ 1,661–2,358 1,397–1,892

*CICT, case investigation and contact tracing. †Including contacts who later become case-patients. Calculated as follows using the observed performance metrics (Table 1), assumed compliance with isolation and quarantine guidance among cases and contacts (Appendix Table 1), and an assumed k = 1.2: [(% case-patients interviewed × compliance) + k × % contacts identified × (% contacts monitored × compliance + % contacts notified but not monitored × compliance)] / (1 + k), where k is approximated from the effective reproduction number (Rt), because undetected infected contacts will infect Rt additional persons on average. During the evaluation period, the average Rt in Philadelphia was 1.29 during periods 1 and 0.99 during period 2. If the assumed compliance was 100%, the estimated effectiveness could be as high as 26% for period 1 and 15% for period 2. ‡The average length of time from infection to isolation and quarantine between case-patients and contacts who later became case-patients. We assumed a 5-day presymptomatic period. We further assumed that interviewed case-patients and notified contacts began isolation and quarantine the day after their interactions with the health department (Appendix). §Calculated by dividing the total staff hours by the estimated number of cases averted by CICT. Lower value represents a more cost-effective program, given that it requires fewer staff hours to prevent each case. ¶Calculated by dividing the total staff hours by the estimated proportion of disease prevalence averted by CICT. Lower value represents a more cost-effective program, given that it requires fewer staff hours to prevent each percentage of disease prevalence.

Main Article

1These first authors contributed equally to this article.

2These senior authors contributed equally to this article.

3Current affiliation: Novo Nordisk, Philadelphia, Pennsylvania, USA.

Page created: December 04, 2023
Page updated: January 24, 2024
Page reviewed: January 24, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external